Last $61.45 USD
Change Today -1.11 / -1.77%
Volume 8.9M
As of 8:04 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for merck & co. inc. (MRK)

Although debt as a percent of total capital increased at Merck & Co. Inc. over the last fiscal year to 32.40%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 61.57 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 145.73 days.
Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Cash and Equivalents10,900.013,531.013,451.015,621.0
TOTAL CASH AND SHORT TERM INVESTMENTS12,201.014,972.016,141.017,486.0
Other Receivables348.0276.0302.0277.0
TOTAL RECEIVABLES7,692.08,537.07,974.07,461.0
Deferred Tax Assets, Current879.0827.0624.0572.0
TOTAL CURRENT ASSETS29,064.033,181.034,857.035,685.0
Gross Property Plant and Equipment30,563.032,473.033,415.033,094.0
Accumulated Depreciation-13,481.0-16,176.0-17,385.0-18,121.0
NET PROPERTY PLANT AND EQUIPMENT17,082.016,297.016,030.014,973.0
Accounts Receivable, Long Term----473.0275.0
Deferred Tax Assets, Long Term472.0497.0527.0381.0
Other Long-Term Assets4,604.04,352.04,423.06,846.0
TOTAL ASSETS105,781.0105,128.0106,132.0105,645.0
Accrued Expenses8,309.09,736.09,203.08,690.0
Short-Term Borrowings2,400.01,990.02,515.02,421.0
Current Income Taxes Payable1,243.0781.01,200.0251.0
Other Current Liabilities, Total1,381.01,715.01,877.02,132.0
TOTAL CURRENT LIABILITIES15,641.016,245.018,348.017,868.0
Long-Term Debt15,489.015,525.016,254.020,564.0
Pension & Other Post-Retirement Benefits3,414.03,805.03,989.01,786.0
Deferred Tax Liability Non-Current7,411.05,626.05,740.06,776.0
Other Non-Current Liabilities7,021.06,984.06,338.06,325.0
Common Stock1,788.01,788.01,788.01,788.0
Additional Paid in Capital40,701.040,663.040,646.040,508.0
Retained Earnings37,536.038,990.039,985.039,257.0
Treasury Stock-22,433.0-23,792.0-24,717.0-29,591.0
TOTAL COMMON EQUITY54,376.054,517.053,020.049,765.0
TOTAL EQUITY56,805.056,943.055,463.052,326.0
TOTAL LIABILITIES AND EQUITY105,781.0105,128.0106,132.0105,645.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $61.45 USD -1.11

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €127.48 EUR 0.00
Gilead Sciences Inc $102.45 USD -2.58
GlaxoSmithKline PLC 1,497 GBp +12.50
Roche Holding AG SFr.251.70 CHF -5.60
Sanofi €81.99 EUR +0.11
View Industry Companies

Industry Analysis


Industry Average

Valuation MRK Industry Range
Price/Earnings 34.2x
Price/Sales 4.2x
Price/Book 4.0x
Price/Cash Flow 33.1x
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at